Pharma Journalist -

Spruce Biosciences which is a clinical-stage biotechnology company developing novel therapies for rare endocrine disorders asserted the launch of its Congenital Adrenal Hyperplasia…
Read More...

OrthoSpin which is a portfolio company of the Trendlines Group declared that it had successfully completed a first-in-human case for smart, robotic external fixation system assuring…
Read More...

The growing global threat of antimicrobial resistance, research strategies aiming to eliminate resistance, latest scientific advancements for tackling resistance, as well as potential…
Read More...

Median Technologies, the industry-leading Imaging Phenomics Company and CMIC HOLDINGS Co., Ltd. (CMIC), a leading Contract Research Organization (CRO) with services for development,…
Read More...

The Medicines Company  declared that its Board of Directors has appointed Dr. Sarah Schlesinger as a new, independent Director of the Company, effective immediately. Dr. Schlesinger…
Read More...

Invicro, a Konica Minolta company asserted that Mr. Edward Hogan, M.S has been appointed as Senior Vice President of Clinical Operations. Mr. Hogan brings extensive medical imaging and…
Read More...

ENYO Pharma SA declared that it is strengthening its leadership team with the appointment of a VP Non-Clinical Development & Product Profiling. ENYO Pharma also confirms that its…
Read More...

ALung Technologies asserted that it has initiated enrolling patient in its VENT-AVOID Trial of the Hemolung RAS. The Minneapolis Heart Institute Foundation recently enrolled the first…
Read More...

Johnson and Johnson Medical Companies asserted that Acclarent,Inc which is a leader in developing minimally-invasive Ear, Nose and Throat technologies has sought clearance from the U.S…
Read More...

Houston-based company specializing in dental sleep medicine and sleep apnea treatment, The Center for Craniofacial & Dental Sleep Medicine (CFDSM) assured that it has sought FDA…
Read More...